In recent work, Kang et al. [33] investigated associations of the expression of immune checkpoint molecules, among others BTLA and HVEM, with prognosis in childhood acute leukemia (AML and ALL). This evidence concerns the gene TNFRSF14 and acute lymphoblastic leukemia.